Prosecution Insights
Last updated: April 19, 2026

Jiangsu Hengrui Pharmaceuticals Co. Ltd.

6 pending office actions

Portfolio Summary

6
Total Pending OAs
0
Final Rejections
6
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18288970 POLYMER AND COMPOSITION THEREOF ALLEY, GENEVIEVE S 1617 Non-Final OA Oct 30, 2023
18550666 NITROGEN-CONTAINING HETEROCYCLIC KETONES, PREPARATION METHODS AND MEDICINAL USES THEREOF SHIAO, REI TSANG 1691 Non-Final OA Sep 14, 2023
18263870 FUSED TRICYCLIC CYCLIN-DEPENDENT KINASE INHIBITOR, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF HABTE, KAHSAY 1624 Non-Final OA Aug 01, 2023
18257325 USE OF NK1 ANTAGONIST PRODRUG COMPOUND IN COMBINATION WITH 5-HT3 RECEPTOR ANTAGONIST MCMILLIAN, KARA RENITA 1623 Non-Final OA Jun 14, 2023
18253704 TRIAZINE DIONE DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN MEDICINE HAVLIN, ROBERT H 1626 Non-Final OA May 19, 2023
18023359 DRUG-LOADED MACROMOLECULE AND PREPARATION METHOD THEREFOR BRANDSEN, BENJAMIN MICHAEL 1693 Non-Final OA Feb 25, 2023

Managing Jiangsu Hengrui Pharmaceuticals Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month